Not Tagged
Not Tagged
['breast']
the oncotype dx breast recurrence score test is the only genomic test proven to predict a patient s individual benefit from chemotherapy. #asco23 #precisiononcology
Delivering genomic testing across the stages of oncology care, with actionable insights to help inform personalized treatment decisions.